509 related articles for article (PubMed ID: 16388984)
1. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.
Zhang C; Buchanan H; Andrews W; Evans A; Pass RF
J Clin Virol; 2006 Mar; 35(3):338-42. PubMed ID: 16388984
[TBL] [Abstract][Full Text] [Related]
2. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
Zhang C; Pass RF
Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
[TBL] [Abstract][Full Text] [Related]
3. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant.
Pass RF; Duliegè AM; Boppana S; Sekulovich R; Percell S; Britt W; Burke RL
J Infect Dis; 1999 Oct; 180(4):970-5. PubMed ID: 10479120
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features.
Zanghellini F; Boppana SB; Emery VC; Griffiths PD; Pass RF
J Infect Dis; 1999 Sep; 180(3):702-7. PubMed ID: 10438357
[TBL] [Abstract][Full Text] [Related]
5. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
6. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
7. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.
Bernstein DI; Schleiss MR; Berencsi K; Gonczol E; Dickey M; Khoury P; Cadoz M; Meric C; Zahradnik J; Duliege AM; Plotkin S
J Infect Dis; 2002 Mar; 185(5):686-90. PubMed ID: 11865427
[TBL] [Abstract][Full Text] [Related]
8. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
9. Use of serial maternal urine cytomegalovirus PCR to detect primary CMV infection in seronegative pregnant women.
Khare M; Sharland M; Manyonda I; Rice P; Bland JM; Griffiths P
J Virol Methods; 2004 Jul; 119(1):31-5. PubMed ID: 15109818
[TBL] [Abstract][Full Text] [Related]
10. Role of cytomegalovirus in sensorineural hearing loss of children: a case-control study Tehran, Iran.
Samileh N; Ahmad S; Mohammad F; Framarz M; Azardokht T; Jomeht E
Int J Pediatr Otorhinolaryngol; 2008 Feb; 72(2):203-8. PubMed ID: 18054797
[TBL] [Abstract][Full Text] [Related]
11. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
[TBL] [Abstract][Full Text] [Related]
13. The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis.
Biri A; Bozdayi G; Ciçfti B; Dinç B; Yücel A; Rota S
Arch Gynecol Obstet; 2006 Feb; 273(5):261-6. PubMed ID: 16001197
[TBL] [Abstract][Full Text] [Related]
14. Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.
Frey SE; Harrison C; Pass RF; Yang E; Boken D; Sekulovich RE; Percell S; Izu AE; Hirabayashi S; Burke RL; Duliège AM
J Infect Dis; 1999 Nov; 180(5):1700-3. PubMed ID: 10515836
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
Bernstein DI; Reap EA; Katen K; Watson A; Smith K; Norberg P; Olmsted RA; Hoeper A; Morris J; Negri S; Maughan MF; Chulay JD
Vaccine; 2009 Dec; 28(2):484-93. PubMed ID: 19857446
[TBL] [Abstract][Full Text] [Related]
16. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
17. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.
Fidouh-Houhou N; Duval X; Bissuel F; Bourbonneux V; Flandre P; Ecobichon JL; Jordan MC; Vildé JL; Brun-Vézinet F; Leport C
Clin Infect Dis; 2001 Oct; 33(8):1406-11. PubMed ID: 11550116
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay for measurement of cytomegalovirus glycoprotein B antibody in serum.
Hackett DJ; Zhang C; Stefanescu C; Pass RF
Clin Vaccine Immunol; 2010 May; 17(5):836-9. PubMed ID: 20219875
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.
den Elzen WP; Vossen AC; Cools HJ; Westendorp RG; Kroes AC; Gussekloo J
Vaccine; 2011 Jun; 29(29-30):4869-74. PubMed ID: 21497631
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of cytomegalovirus infection in kindergarten children.
Shen CY; Chang BL; Chang SF; Yang SL; Tseng SL; Chen CY; Wu CW
J Med Virol; 1996 Jan; 48(1):33-7. PubMed ID: 8825707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
